|
TPRKB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63424829224823E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.45563594300802E-13 |
| Normal-vs-Stage2 |
3.080200E-03 |
| Normal-vs-Stage3 |
2.06979999806123E-08 |
| Normal-vs-Stage4 |
2.22129999949416E-08 |
| Stage1-vs-Stage2 |
6.986000E-01 |
| Stage1-vs-Stage3 |
9.789000E-01 |
| Stage1-vs-Stage4 |
2.998200E-01 |
| Stage2-vs-Stage3 |
7.021600E-01 |
| Stage2-vs-Stage4 |
4.326200E-01 |
| Stage3-vs-Stage4 |
4.240000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62581059726108E-12 |
| Normal-vs-AfricanAmerican |
1.309530E-02 |
| Normal-vs-Asian |
5.835600E-02 |
| Caucasian-vs-AfricanAmerican |
2.913800E-02 |
| Caucasian-vs-Asian |
6.672300E-02 |
| AfricanAmerican-vs-Asian |
9.491000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.37740041594725E-10 |
| Normal-vs-Female |
1.63180580159406E-12 |
| Male-vs-Female |
1.696250E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.977400E-04 |
| Normal-vs-Age(41-60Yrs) |
9.66359992027321E-10 |
| Normal-vs-Age(61-80Yrs) |
2.50577336657898E-13 |
| Normal-vs-Age(81-100Yrs) |
5.162400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.657200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.753600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.104200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.009000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.316200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.865600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.82820000000206E-05 |
| Normal-vs-Grade 2 |
2.1449508835758E-13 |
| Normal-vs-Grade 3 |
9.45765687987432E-12 |
| Normal-vs-Grade 4 |
1.983950E-03 |
| Grade 1-vs-Grade 2 |
5.642200E-01 |
| Grade 1-vs-Grade 3 |
8.572400E-01 |
| Grade 1-vs-Grade 4 |
2.249600E-01 |
| Grade 2-vs-Grade 3 |
1.272960E-01 |
| Grade 2-vs-Grade 4 |
1.657220E-03 |
| Grade 3-vs-Grade 4 |
3.656000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
4.403900E-02 |
| ccA subtype-vs-ccB subtype |
1.62525548574877E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.15280049132139E-11 |
| Normal-vs-N1 |
6.715700E-02 |
| N0-vs-N1 |
1.900440E-01 |
|
|
